TEL AVIV, Israel, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS) (Medigus), a technology company engaged in innovative internet technologies, electric vehicle and charging solutions and advanced medical solutions, today announced financial results for the six-month periods ended June 30, 2023.
H1 2023 and recent highlights:
- Medigus revenues reached $53.3 million in the first six months of 2023, compared to $35 million in the first six months of 2022, representing a 52% increase;
- Medigus subsidiary for EV Wireless Charging, Charging Robotics, merged with a public company in the US and commenced trading on the OTC Market (OTCMKTS: FDOC);
- Medigus sold its entire stake in Odysight.ai Inc. (formerly known as Scoutcam Inc.) for approximately $5.7 million in cash;
- Drone safety company, ParaZero (PRZO), commenced trading on Nasdaq, following a $7.8 million initial public offering (IPO);
- Jeffs Brands (JFBR) revenues for the first six months of 2023 totaled $3.9 million, compared to $2.3 million in the first six months of 2022, representing a 65% increase;
- Viewbix (OTC: VBIX) reported its condensed consolidated financial results for the first half of 2023 with revenues totaling $48 million, an increase of 10% compared to the first half of 2022; and
- Eventers revenues for the first six months of 2023 amounted to approximately $1.5 million with net profit for the first time.
We are thrilled to report a great first half of 2023 for Medigus. Our revenue growth, reaching $53.3 million, showcases a substantial 52% increase compared to the same period last year, reflecting our teams unwavering commitment to excellence and strategic foresight, said Liron Carmel, Chief Executive Officer of Medigus. The successful IPO of ParaZero, exciting merger of our subsidiary, Charging Robotics, with a US public company and the sale of our Odysight.ai Inc stake are all testaments to our strategic moves to optimize shareholder value.
Mr. Carmel added, Were also pleased with Viewbixs commendable performance. As we move forward, the expiration of all our listed warrants ensures a simplified capital structure in addition to our cash boost as a result of the sale of Odysight.ai Inc. At Medigus, we are always striving to pioneer, innovate, and grow, and we remain excited for what the future holds for our company and our stakeholders.
The Companys gross profit for the first half of 2023 was approximately $8.2 million, compared to a gross profit of approx. $6.1 million in the first half of 2022. Operating loss for the six months ended on June 30, 2023, was $9.8 million, compared to operating loss for the six months ended on June 30, 2022, of approx. $6.3 million.
About Medigus
Based in Israel, Medigus Ltd. (Nasdaq: MDGS) is a technology company focused on innovative growth partnerships, engaged in innovative internet technologies, electric vehicle and charging solutions and advanced medical solutions. Medigus affiliations in the medical solutions arena include ownership in Polyrizon Ltd. The Companys affiliates in digital commerce include Gix Internet Ltd., Jeffs Brands Ltd. and Eventer Technologies Ltd. In the electric vehicle market, Charging Robotics Ltd. and Revoltz Ltd. by way of Fuel Doctor Holdings, Inc., are also part of the Companys portfolio of technology solution providers. Medigus is traded on the Nasdaq Capital Market. To learn more about Medigus advanced technologies, please visit http://www.medigus.com/.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as expects, anticipates, intends, plans, believes, seeks, estimates and similar expressions or variations of such words are intended to identify forward-looking statements. Because such statements deal with future events and are based on Medigus current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements of Medigus could differ materially from those described in or implied by the statements in this press release.
The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed in any filings with the SEC. Except as otherwise required by law, Medigus undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Medigus is not responsible for the contents of third-party websites.
Company Contact:
Tali Dinar
Chief Financial Officer
+972-8-6466-880
ir@medigus.com
Investor Relations Contact:
Michal Efraty
Investor Relations, Israel
+972-(0)52-3044404
michal@efraty.com
MEDIGUS LTD.
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
June 30,
2023 | December 31, 2022 | |||||||||
Unaudited | Audited | |||||||||
USD in thousands | ||||||||||
ASSETS | ||||||||||
CURRENT ASSETS: | ||||||||||
Cash and cash equivalents | 12,359 | 20,065 | ||||||||
Short term deposits | 11 | 859 | ||||||||
Restricted cash | 182 | 185 | ||||||||
Trade accounts receivable | 18,981 | 21,449 | ||||||||
Receivable from sale of shares | 5,774 | - | ||||||||
Other receivables | 2,015 | 1,928 | ||||||||
Inventory | 2,543 | 1,791 | ||||||||
Loans to associates | 1,181 | 546 | ||||||||
Loans to others | 1,017 | 1,011 | ||||||||
Related parties | 238 | 298 | ||||||||
Financial assets at fair value through profit or loss | 2,243 | 4,126 | ||||||||
46,544 | 52,258 | |||||||||
NON-CURRENT ASSETS: | ||||||||||
Property and equipment, net | 384 | 408 | ||||||||
Right-of-use assets, net | 598 | 591 | ||||||||
Investments accounted for using the equity method | 5,454 | 11,892 | ||||||||
Intangible assets, net | 31,036 | 30,862 | ||||||||
Deferred tax asset | 458 | 397 | ||||||||
Financial assets at fair value through profit or loss | 1,193 | 1,243 | ||||||||
39,123 | 45,393 | |||||||||
TOTAL ASSETS | 85,667 | 97,651 |